73 results about "Blood test result" patented technology

The present invention relates to methods and systems for providing an animal with a nutraceutical program that is specifically tailored to address the deficiencies and / or needs of the particular animal. Blood is drawn from the animal and analyzed at a lab to obtain blood test results. The blood test results are scored to obtain at least one blood test score for at least one corresponding blood parameter. If the at least one blood test score falls within a normal range but outside of an optimal range, one or more nutraceuticals needed to bring the animal within the optimal range for the at least one corresponding blood parameter are identified. A prescribed dosage amount is then calculated for at least one of the one or more identified nutraceuticals for the animal. The calculation of the prescribed dosage amount is based on at least the blood test score for the corresponding blood parameter and a deviation of the blood test score from the optimal range.

An image interpretation report creating apparatus for displaying a case in combination of an image interpretation report and a blood test result even if they are stored in different computers. The apparatus includes: a display unit for displaying an image interpretation report creation screen along with a blood test result; an input unit for specifying finding and a blood test result; a search key generating unit for generating search keys for searching an image interpretation report DB and a blood test result DB; a search processing unit for causing an image interpretation report server and an examination result server to obtain cases that match the search keys; a similarity degree determining unit for displaying the cases in an order of the degree of similarity; and an image interpretation report preservation unit for causing the image interpretation report server to store image interpretation report data.

Methods, systems, and computer storage media are provided for enabling management of a patient's blood when the patient has a scheduled elective procedure. Blood test results are received for the patient and are recorded in the patient's electronic medical record (EMR). It is determined that the elective procedure is associated with a high risk of blood loss. Based on the blood test results, it is determined that the patient requires blood treatment prior to the elective procedure. Blood treatment instructions are automatically determined and are displayed on the patient's EMR such that the clinician associated with the patient can review the instructions and determine if the patient will receive any or all of the recommended blood treatment prior to the elective procedure.

Decades of investigations were focused on finding “gold standard” for evaluation of plasma dilution and osmolality, blood loss evaluation and prediction of bleeding or transfusion induced changes in hematocrit and hemoglobin concentration. Addressing deficiencies of existing methods, the current invention created new combined mathematical-physiological model applicable to manually operated nomograms and software in medical monitors. The mathematical model HBS Trends is used in blood transfusion and infusion therapy nomogram—HBS Nomogram—which is based on blood hemoglobin concentration and hematocrit. It is also an easy and practical tool for recording and dynamical interpretation of plasma osmolality, blood hemoglobin concentration, hematocrit and mean corpuscular hemoglobin concentration. The HBS Nomogram is a practical system for organizing blood test results in a patient's medical records. It can be used alone or, in line with existing guidelines for infusion and transfusion therapy making them more practical, cost effective and time saving in decision making.

The invention provides a full-automatic blood sampling management system and method. According to the system and method, a number taking system, a main control system, a hospital LIS system, a labeling and code scanning system and a number calling system are associated to realize the interconnection of information, the medical personnel in each link can timely and correctly obtain the blood sampling item information of the patients, and the patients can conveniently know the blood sampling item information and moderately decide the approximate time of blood sampling according to the intentions, so that the problems of high manpower and material resource consumption, high operation error rate and low blood sampling process operation efficiency in the blood sampling management processes in hospitals can be solved, convenience is brought to the medical personnel or the patients to query the blood sampling item information, and the management for the blood sampling process, the blood sampling progress and the filing and query aiming at the blood test results of the patients in later period are facilitated.

A method of evaluating gastrointestinal cancer risk. The method comprises generating a set of features comprising a plurality of current blood test results from a blood collected from a target individual, providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals, and evaluating, using a processor, a gastrointestinal cancer risk of the target individual by classifying the set of features using the at least one classifier.

The present invention relates to methods and systems for providing an animal with a nutraceutical program that is specifically tailored to address the deficiencies and / or needs of the particular animal. Blood is drawn from the animal and analyzed at a lab to obtain blood test results. The blood test results are scored to obtain at least one blood test score for at least one corresponding blood parameter. If the at least one blood test score falls within a normal range but outside of an optimal range, one or more nutraceuticals needed to bring the animal within the optimal range for the at least one corresponding blood parameter are identified. A prescribed dosage amount is then calculated for at least one of the one or more identified nutraceuticals for the animal. The calculation of the prescribed dosage amount is based on at least the blood test score for the corresponding blood parameter and a deviation of the blood test score from the optimal range.

The present invention relates to in vitro prognostic method for assessing the risk of death or of liver-related event in a subject, comprising: a. obtaining at least one, preferably at least 2, of the following variables from the subject: i. biomarkers measured in a sample from the subject; ii. clinical data; iii. binary markers; iv. blood test results; b. optionally obtaining at least one blood test result by univariate combination, preferably with a binary logistic regression, of the at least one variable obtained in step (a), said blood test not being a Fibrotest, c. obtaining at least one physical data from medical imaging or clinical measurement, preferably from elastometry, more preferably from Vibration Controlled Transient Elastography (VCTE), and d. mathematically combining in a multivariate time-dependent model said at least one variable obtained in step (a) and / or said at least one blood test result obtained in step b); and said at least one physical data, obtained in step (c) thereby obtaining a prognostic score.

The invention discloses an early warning system based on independent risk factor combinatory screening. In the system, an input module of the system is used for inputting personal basic information of a user to be detected, a selector module is used by the user to be detected, to select a blood test scheme to be carried out, a blood sampling device is used for collecting blood of the user to be detected, a blood tester is used for detecting type of the chosen blood test scheme for the collected blood of the user to be detected, a data processing module is used for receiving blood test results transmitted by the blood tester, comparing the blood test results with pre-stored reference data, and transmitting comparison results and conclusions to a results processing module after comparison is complete, and the results processing module is used for processing the received comparison results and conclusions, and transmitting the processed results to a results output module for displaying. The system and method carry out detection in a most convenient and feasible manner, attack rate of serious diseases and death rate are decreased, and the cost is low.

An image interpretation report creating apparatus for displaying a case in combination of an image interpretation report and a blood test result even if they are stored in different computers. The apparatus includes: a display unit for displaying an image interpretation report creation screen along with a blood test result; an input unit for specifying finding and a blood test result; a search key generating unit for generating search keys for searching an image interpretation report DB and a blood test result DB; a search processing unit for causing an image interpretation report server and an examination result server to obtain cases that match the search keys; a similarity degree determining unit for displaying the cases in an order of the degree of similarity; and an image interpretation report preservation unit for causing the image interpretation report server to store image interpretation report data.

The invention relates to a vacuum blood collection tube, and belongs to the technical field of medical equipment. According to the technical scheme, the vacuum blood collection tube comprises a vacuum tube body, a sealing plug used for sealing the vacuum tube body, and a cap used for fixing the sealing plug, a detachable damping baffle is arranged on the upper portion in the vacuum tube body to divide the tube body into the upper portion and the lower portion, a diversion port is formed in the detachable damping baffle, a spiral guiding channel is annularly formed in the inner wall of the tube body, and a label bag used for accommodating labels is arranged on the outer wall of the vacuum tube body. The vacuum blood collection tube has the advantages of being reasonable in structure, good in using effect, and capable of reducing the probability of hemolysis, thereby guaranteeing the reliability of blood test result data.

The invention discloses an intelligent full-automatic blood sampling management system, and belongs to the technical field of blood sampling. The intelligent full-automatic blood sampling management system comprises a blood sampling service terminal, a main control module and a blood sampling management module. The problems that in the prior art, when blood is examined, medical workers need to carry out chemical examination according to examination information of a patient, errors occur, manpower and material resources are easily consumed, and efficiency is low are solved, the blood examination requirement of the patient can be rapidly determined when blood chemical examination is carried out, and the blood examination efficiency is improved. The accuracy of blood examination requirements is guaranteed, manual confirmation of medical staff is not needed, the problems that in the blood sampling management process of a hospital at present, manpower and material resources are consumed, the operation error rate is high, and the operation efficiency of the blood sampling process is low can be solved, convenience is provided for medical staff or patients to inquire blood sampling item information, and the blood sampling efficiency is improved. And the blood sampling process, the blood sampling progress and the filing and query management of the blood test result of the patient in the later period are facilitated.

The invention discloses a system for blood test services provided by primary medical institutions and an application method thereof. The system comprises a clinic management subsystem, a supplier product and LIS management subsystem, a blood test product subsystem, a blood test ordering subsystem, a logistics sampling subsystem and an online report subsystem. The system is advantaged in that through Internet medical treatment, doctors in the primary medical institutions can order blood test products for patients in the system and finally check blood test result reports, so patient's diseases are determined in combination with the clinical results, the system enables clinics to have the large hospital laboratory function, the patients are effectively distributed to seek medical attention locally, and the country's grading diagnosis and treatment policy is implemented.

A method of evaluating gastrointestinal cancer risk. The method comprises generating a set of features comprising a plurality of current blood test results from a blood collected from a target individual, providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals, and evaluating, using a processor, a gastrointestinal cancer risk of the target individual by classifying the set of features using the at least one classifier.

A method of evaluating lung cancer risk by generating a set of features comprising a plurality of current blood test results from a blood collected from a target individual, providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals, and evaluating, using a processor, a lung cancer risk of said target individual by classifying said set of features using said at least one classifier. Each of said plurality of historical and current blood test results comprises results of one or more selected blood tests such as white blood cells blood test results, biochemistry test results, platelets blood test results including at least one of platelets count and mean platelet volume (MPV) and / or a combination of smoking history and red cell test results.

Disclosed are a method and a system using user personal, CBC, CMP and Lipid Panel data to detect a user acute myocardial infarction (AMI) risk and help user monitor AMI risk. Most AMI risk screening and diagnosis are related with the markers, video, image data, etc. although past researches have shown that serum albumin, RBC, MCV, MPV and PDW are all significantly correlated with AMI risk, use of the blood test results of CBC, CMP and Lipid Panel data to detect and monitor AMI risk has never been reported. Traditionally, AMI risk detecting and monitoring have been managed by doctors and hospitals and a user is unable to do it by himself or herself. The purpose of this invention is to provide an intelligent AMI risk detecting and monitoring system enabling users to detect and monitor AMI risk.

The invention discloses a blood collection tube for medical clinical examinations, and relates to the technical field of medical clinical examinations. The blood collection tube comprises a tube body,wherein the top of the tube body is movably connected with a safety cap, a rubber plug is fixedly connected between two sides of the inner wall of the safety cap, and the bottom of the rubber plug runs through the tube body and extends to the inside the tube body. According to the invention, through adopting polylactic acid and polyvinyl alcohol as the main materials for the preparation of the blood collection tube, the biodegradable ability of the blood collection tube can be accelerated, and the blood collection tube is much faster in degradation speed than conventional blood collection tubes on the market, causing no pollution to environment after the blood collection tube is abandoned; meanwhile, the antibacterial ability of the blood collection tube can be greatly improved by using anti-bacterial agents and bis-quaternary ammonium salts, and a cooperated use of sodium citrate and sodium citrate can play a good anti-coagulation role; the above-mentioned materials adopted in the invention are common materials on the market, so that the economic cost is lower; and the invention establishes a basis for the accuracy of subsequent blood test results.

The present invention relates to methods and systems for providing an animal with a nutraceutical program that is specifically tailored to address the deficiencies and / or needs of the particular animal. Blood is drawn from the animal and analyzed at a lab to obtain blood test results. The blood test results are scored to obtain at least one blood test score for at least one corresponding blood parameter. If the at least one blood test score falls within a normal range but outside of an optimal range, one or more nutraceuticals needed to bring the animal within the optimal range for the at least one corresponding blood parameter are identified. A prescribed dosage amount is then calculated for at least one of the one or more identified nutraceuticals for the animal. The calculation of the prescribed dosage amount is based on at least the blood test score for the corresponding blood parameter and a deviation of the blood test score from the optimal range.

A pet blood tester includes a reader configured to read identification information of a pet from a tag; an analyzer configured to analyze blood of the pet to acquire information on the blood; a storage; a controller configured to receive stored body information of the pet corresponding to the identification information from at least one of an external device and the storage if the stored body information of the pet corresponding to the identification information is stored in at least one of the external device and the storage; and an inputter configured to receive input body information of the pet from a user if the body information of the pet corresponding to the identification information is not stored in at least one of the external device and the storage, wherein the controller is further configured to provide a blood test result and diagnosis information for the pet, based on the information on the blood, and the stored body information of the pet or the input body information on the blood.

The present disclosure relates to alternative methods of conducting standard blood chemistry tests, the methods typically comprising: extracting an RNA from a blood sample, determining a mRNA level of a predictive gene in the blood sample, and converting the mRNA level of the predictive gene into the blood test result of the target blood component. The present disclosure also relates to blood test for performing the proxy methods. The blood test includes a plasmid with at least an exon of a predictive gene, a reagent for detecting a mRNA level of the predictive gene, and a reagent for detecting a mRNA level of a housekeeping gene.

The present application provides a method for detecting pseudo-lesions of the fundus, comprising: performing image feature analysis of the lesion area according to preliminary lesion markings, locating and evaluating the cell density and the degree of vascular leakage, and determining the risk of disease aggravation; predicting the tortuosity and vascular fragility of new blood vessels and evaluating the probability of complications in patients according to morphological processing and feature analysis of multi-phase vascular images; predicting the risk of serious complications according to the lesion markings and vascular feature analysis of the patient, combined with blood test results, and re-identifying and excluding pseudo-lesion images that are mistaken for lesion images; comparing the feature changes of pseudo-lesions and real lesion areas according to time series analysis of fundus disease images, evaluating the disease development path, and performing early intervention on the disease; segmenting the new blood vessel area based on the use of sensitive index filtering technology, and evaluating the risk of disease aggravation through vascular feature statistics.

The invention discloses a device for predicting the severity of COVID-19 patients, which belongs to the intelligent processing technology of medical data. The invention includes: an input module for inputting patient information; a data preprocessing module for performing data preprocessing on the data output by the input module, if it is training data, then send the processing result to the feature selection module, if it is the data to be predicted , the processing result is sent to the prediction processing module; the feature selection module selects a certain number of features from the input features as the input feature selection result; the prediction processing module inputs the characteristic information of the patient into the preset prediction model, and The prediction results are sent to the prediction result output module for visual output. The present invention selects key features from the blood test results of patients to ensure the accuracy of prediction of severe COVID-19 patients, realizes medical assistance for rapid triage of patients with COVID-19, helps to optimize medical resources and Prompt medical intervention.

The present invention discloses a blood oscillation and mixing device for blood testing, which belongs to the technical field of blood testing and comprises a processing box, a rotating plate, a stepping motor, a sliding rod, an elastic clamping ring, a propulsion mechanism, a placement slide rail, a supporting plate and a resistance and closing mechanism. The present invention effectively ensures the installation convenience and stability of the multiple blood sample test tubes by synchronously propulsing and resisting, closing and clamping installation of the multiple blood sample test tubes through the propulsion mechanism and the resistance and closing mechanism, and through the setting of the planetary transmission mechanism and the driving of the stepping motor, the supporting plate and the blood sample test tubes are rolled on the fixed gear ring in the processing box, so that the movement trajectory of the blood sample test tubes is more diverse, and the blood sample is oscillated and mixed more evenly, providing sufficient guarantee for the accuracy of the subsequent blood test results.

We provide the system. [Solution] A system that provides medical second opinions using a generative artificial intelligence device, A means for inputting blood test results using an input device, A means for inputting the results of the medical interview and physical examination, A means of integrating the above blood test results with the results of the medical interview and physical examination, A means for inputting integrated data into a generative artificial intelligence model to generate multiple treatment plans, A means for providing the generated treatment plan to healthcare professionals and patients via a display means, A means for selecting the optimal treatment plan and saving that treatment plan using a final decision-making mechanism, A system that includes this.

The utility model belongs to the technical field of medical treatment. The utility model discloses a blood sampling device which comprises an injector composed of a piston cylinder used for collecting a blood sample and a needle used for puncturing and sampling blood. An opening is formed in the piston cylinder, a connector is arranged on the opening of the piston cylinder in a sleeving manner, a rubber plug used for isolating communication between a cavity of the piston cylinder and external air during working is embedded in the connector, the needle head is arranged on the connector in a sleeving manner, and one end of the needle head penetrates through the rubber plug to be communicated with the cavity of the piston cylinder; the needle head is sleeved with a protective sleeve structure used for preventing needle stick injury and blood sample pollution. The blood sampling device has the advantages that the risks that medical staff are punctured by needles and blood samples are polluted due to contact are not easily caused in the blood sampling process, and the blood samples are not easily polluted by external air, so that the subsequent blood test result is not influenced.

The invention discloses a plasma matrix product attribute parameter determination method based on blood analysis data. The method comprises the following steps: acquiring multiple groups of blood analysis sample data and plasma matrix preparation sample data; performing model training based on a mapping relation between the blood analysis sample data and the plasma matrix preparation sample data to obtain a plasma matrix product attribute parameter prediction model; and processing to-be-detected blood detection data based on the prediction model to obtain corresponding plasma matrix product attribute parameter prediction data. Correlation analysis is carried out on blood test results of different patients and plasma matrix preparation effects in advance, learning simulation is carried out on the relation between the blood test results and the plasma matrix preparation effects, the plasma matrix product attribute parameter prediction model is obtained, then model application can be carried out on whole blood analysis results of the patients in the plasma matrix preparation process, and the prediction accuracy of the plasma matrix product attribute parameters is improved. Plasma matrix product attribute parameter data most matched with the blood condition of a specific patient is obtained, and subsequent parameter adjustment is facilitated, so that the preparation effect of the plasma matrix is guaranteed.

The invention discloses a dual-protection vacuum blood collection tube, which comprises a tube body, an inner liner tube and a seal ring, the inner liner tube is contained in the tube body, the orifice brim of the inner liner tube is wrapped by the seal ring, moreover, the inner liner tube is elastically fastened on the inner wall of the tube body by the seal ring, a PP (polypropylene) test tube is adopted as the inner liner tube, a plastic tube is adopted as the tube body, and furthermore, the upper end of the tube body is provided with a protective gas layer. The dual-protection vacuum blood collection tube is integrated with the non-fragility of the single PET (polyethylene terephthalate) plastic tube and the waterproofness of the PP test tube, and utilizes the protective gas layer to isolate a blood sample from contacting with the air, thus ensuring the accuracy of a blood test result, the entire structure is simple, and the practicability is high.

The present invention belongs to the field of prognosis of pesticide poisoning. Specifically disclosed is a method for establishing a mortality risk prediction index for acute diquat pesticide poisoning, comprising: collecting data; establishing a mortality risk index model based on demographic characteristics and routine blood test results; and training, internally validating, and externally validating the model. The mortality risk index provided by the present invention comprehensively considers age, blood concentration of diquat, white blood cell count, and aspartate aminotransferase concentration, aiming to accurately evaluate, in the form of an index, the mortality risk of patients suffering from acute diquat pesticide poisoning. Through in-depth analysis of large-scale clinical data, the mortality risk index of the present invention possesses scientific validity and accuracy at the data level, and can also play an important role in clinical practice. Further, the present invention can be applied to construct a terminal device for predicting the mortality risk of acute diquat pesticide poisoning, assisting medical teams in more reasonably allocating medical resources and prioritizing high-risk patients, thereby improving overall treatment outcomes and the patients' chances of survival.